- Latest week
- 10 Jul 2026
- Close
- 250.300003
- Fair value
- 245.877884
- Next-week expectancy
- Undecided 52.08%
GMAB Chart Pack
Genmab A/S
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, GMAB rose 9.16%, moving from 229.30 to 250.30. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -16.42 and has softened across the 12-week window. Market Dynamics is 0.59 on the latest week. Next-week expectancy is undecided at 52.08% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 250.30
- 12-Week Change
- 9.16%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 52.08%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -16.42
- Market Dynamics
- 0.59
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 250.30
- 12-Week Change
- 9.16%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 52.08%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -16.42
- Market Dynamics
- 0.59
Over the latest 12 completed weeks ending 2026-07-10, GMAB rose 9.16%, moving from 229.30 to 250.30. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -16.42 and has softened across the 12-week window. Market Dynamics is 0.59 on the latest week. Next-week expectancy is undecided at 52.08% based on similar historical setup states.
Industry Peers
Austria equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| VVYN Vivoryon Therapeutics N.V. | VIE | 10 Jul 2026 | 1.11 | 1.50 | 1.10 | 1.38 | 24.43% |
| HPHA Heidelberg Pharma AG | VIE | 10 Jul 2026 | 2.59 | 2.74 | 2.59 | 2.66 | 2.70% |
| REGN Regeneron Pharmaceuticals, Inc. | VIE | 10 Jul 2026 | 575.80 | 593.70 | 560.00 | 578.90 | 0.54% |
| PHM Pharma Mar, S.A. | VIE | 10 Jul 2026 | 79.48 | 83.04 | 78.99 | 79.40 | -0.10% |
| ALKB ALK-Abelló A/S | VIE | 10 Jul 2026 | 32.66 | 32.76 | 32.12 | 32.48 | -0.55% |
| BMRN BioMarin Pharmaceutical Inc. | VIE | 10 Jul 2026 | 52.12 | 53.02 | 51.06 | 51.72 | -0.77% |
| TUBI Financière de Tubize SA | VIE | 10 Jul 2026 | 222.00 | 222.00 | 214.60 | 218.80 | -1.44% |
| LKFT Lakefront Biotherapeutics NV | VIE | 10 Jul 2026 | 26.86 | 26.88 | 26.44 | 26.44 | -1.56% |
| FYB Formycon AG | VIE | 10 Jul 2026 | 19.46 | 19.46 | 18.26 | 18.84 | -3.19% |
| MARI Marinomed Biotech AG | VIE | 10 Jul 2026 | 9.50 | 9.50 | 8.70 | 9.15 | -3.68% |
| BAVA Bavarian Nordic A/S | VIE | 10 Jul 2026 | 25.68 | 25.68 | 24.38 | 24.56 | -4.36% |
| VLA Valneva SE | VIE | 10 Jul 2026 | 2.33 | 2.35 | 2.20 | 2.20 | -5.74% |
| NVAX Novavax, Inc. | VIE | 10 Jul 2026 | 8.51 | 8.53 | 7.88 | 7.94 | -6.70% |
| ZEAL Zealand Pharma A/S | VIE | 10 Jul 2026 | 40.57 | 40.57 | 37.75 | 37.75 | -6.95% |
| VRTX Vertex Pharmaceuticals Incorporated | VIE | 10 Jul 2026 | 462.10 | 463.00 | 423.60 | 424.75 | -8.08% |
| ARGX argenx SE | VIE | 10 Jul 2026 | 830.60 | 830.60 | 763.00 | 763.00 | -8.14% |